Prostate Cancer

Results of their study were published in the Feb.

15 issue of Clinical Cancer Research.

"This is good news in an area where our ability to diagnose and predict has previously been less than stellar," said Krishna Donkena, Ph.D., Mayo Clinic urologic researcher.

"Our only tool is the PSA test, which has little predictive value.

These findings move us much closer to a more accurate test." The search to identify biomarkers that can be translated into affordable and effective medical tests can be complicated.

They also may be used to provide i...

Read more...